The use of opioids in children receiving intrathecal baclofen therapy
Tóm tắt
We hypothesized that children on chronic intrathecal baclofen therapy (ITB) may require less analgesics for postoperative pain control and are at higher risk of developing opioid-induced respiratory depression postoperatively. The aims of this study are to review children on chronic intrathecal baclofen therapy receiving opioids after major surgery and to determine the incidence complications in this population. We conducted a retrospective cohort study comparing 13 children on ITB, who underwent posterior spinal fusion surgery, to 17 children with spina bifida that received the same surgery. On postoperative day 0 (POD 0), four children (40%) had respiratory depression in the baclofen group compared to none in the control group. Desaturation was significantly more frequent in children in the ITB group compared to those of the control group on POD 0; oversedation was recorded in 8 (80%) children in the baclofen group vs. 3 (17.6%) in the control group. Desaturation, respiratory depression, and oversedation were significantly more frequent on POD 0 in children in the baclofen group compared with children in the control group. The findings of the current study suggest that children on chronic intrathecal baclofen therapy require lesser amounts of opioids for postoperative pain control and are at a greater risk of developing postoperative respiratory depression and excessive sedation compared to patients without baclofen therapy.
Tài liệu tham khảo
Gilmartin R, Bruce D, Storrs BB, Abbott R, Krach L, Ward J, Bloom K, Brooks WH, Johnson DL, Madsen JR, McLaughlin JF, Nadell J (2000) Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 15:71–77. https://doi.org/10.1177/088307380001500201
Albright AL, Barry MJ, Painter MJ, Shultz B (1998) Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurosurg 88:73–76. https://doi.org/10.3171/jns.1998.88.1.0073
Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87:409–414. https://doi.org/10.3171/jns.1997.87.3.0409
Buonaguro V, Scelsa B, Curci D, Monforte S, Iuorno T, Motta F (2005) Epilepsy and intrathecal baclofen therapy in children with cerebral palsy. Pediatr Neurol 33:110–113
Butler C, Campbell S, Adams R, Abel M, Chambers H, Goldstein M, Leach J, Darrah J, Msall M, Edgar T, McLaughlin J, Damiano D, Stott NS, Samson-Fang L, Logan L, Albright L, Armstrong R, O’Donnell M (2007) Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev Med Child Neurol 42:634–645. https://doi.org/10.1111/j.1469-8749.2000.tb00371.x
Bucholz R (1994) Management of intractable spasticity with intrathecal baclofen. Phys Med Rehabil 8:565–577
Albright AL (1996) Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 11(Suppl 1):S29–S35. https://doi.org/10.1177/0883073896011001S05
Belelli D, Pistis M, Peters JA, Lambert JJ (1999) General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol Sci 20:496–502
Gordon NC, Gear RW, Heller PH, Paul S, Miaskowski C, Levine JD (1995) Enhancement of morphine analgesia by the GABAB agonist baclofen. Neuroscience 69:345–349
Dickenson AH, Brewer CM, Hayes NA (1985) Effects of topical baclofen on C fibre-evoked neuronal activity in the rat dorsal horn. Neuroscience 14:557–562. https://doi.org/10.1016/0306-4522(85)90310-0
Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S (1997) The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 23:293–297
Bowery NG, Enna SJ (2000) γ-Aminobutyric acid (B) receptors: first of the functional metabotropic heterodimers. J Pharmacol Exp Ther 292:2–7
Gooch JL, Oberg WA, Grams B, Ward LA, Walker ML (2003) Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 39:1–6. https://doi.org/10.1159/000070870
Anderson KJ, Farmer JP, Brown K (2002) Reversible coma in children after improper baclofen pump insertion. Paediatr Anaesth 12:454–460. https://doi.org/10.1046/j.1460-9592.2002.00844.x
Dressnandt J, Weinzierl FX, Tolle TR et al (1996) Acute overdose of intrathecal baclofen. J Neurol 243:482–483
Nolan J, Chalkiadis GA, Low J et al (2000) Anaesthesia and pain management in cerebral palsy. Anaesthesia 55:32–41. https://doi.org/10.1046/j.1365-2044.2000.01065.x
Perry HE, Wright RO, Shannon MW, Woolf AD (1998) Baclofen overdose: drug experimentation in a group of adolescents. Pediatrics 101:1045–1048
Gerszten PC, Albright a L, Johnstone GF (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 88:1009–1013. https://doi.org/10.3171/jns.1998.88.6.1009
Dapas F, Hartman SF, Martinez L et al (1985) Baclofen for the treatment of acute low-back syndrome: a double-blind comparison with placebo. Spine (Phila Pa 1976) 10:345–349. https://doi.org/10.1097/00007632-198505000-00010
(1994) Geigy Pharmaceutical Lioresal. In: Physicians’ Desk reference. pp 1063–4
Franek M, Vaculín S, Rokyta R (2004) GABA(B) receptor agonist baclofen has non-specific antinociceptive effect in the model of peripheral neuropathy in the rat. Physiol Res 53:351–355
Levy RA, Proudfit HK (1979) Analgesia produced by microinjection of baclofen and morphine at brain stem sites. Eur J Pharmacol 57:43–55. https://doi.org/10.1016/0014-2999(79)90102-X
Spano MS, Fattore L, Fratta W, Fadda P (2007) The GABAB receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology 52:1555–1562. https://doi.org/10.1016/j.neuropharm.2007.02.012